Abstract

Short Review

Morular Metaplasia of the Endometrium: A Case Report and Literature Review: Care Pathways based on Molecular Biology

Dhanushka SK Kotigala and Tolu O Adedipe*

Published: 30 April, 2024 | Volume 7 - Issue 2 | Pages: 059-062

Background: Endometrial morular metaplasia, a clinical conundrum from a diagnostic and management angle given its rarity and low oncogenic potential, has been linked to endometrial hyperplasia and carcinoma. 
Case report: A 77-year-old woman with no significant past medical history, was found to have an asymptomatic thickened endometrium on pelvic imaging, after presenting with lower abdominal pain, 3yrs ago. Diagnostic hysteroscopy identified an endometrial polyp within a pyometra. Histopathology showed focal complex endometrial hyperplasia without atypia with superimposed morular metaplasia(EMM) with a negative microbiology assay.
Following conservative management with multidisciplinary team(MDT) overview, as-per patient choice with 6-monthly follow-up hysteroscopy, endometrial biopsies and a short use of the Mirena® Intrauterine system (discontinued following poor tolerance), histopathology shows resolved hyperplasia with persistent EMM. Due to persistent disease, a hysterectomy is under consideration.
Discussion: Current evidence suggests that a sub-type of EMM, a likely histological manifestation of beta-catenin (CTNNB1) gene mutation: could be a precursor of endometrial hyperplasia and low-grade endometrioid-endometrial carcinoma sub-type. Though low-grade in nature, the increased recurrence risk raises significant concerns.
Prognostication following gene mutation identification can help with management options which include conservative, hormonal therapy with adjunct repeat endometrial sampling: or hysterectomy. The optimal frequency of endometrial sampling when uterine-sparing, is unclear, leading to a management conundrum, whilst persistent disease may require a hysterectomy.
Conclusion: Management of endometrial morular metaplasia can be difficult but must reflect the woman’s choice with a MDT-overview. Immuno-histochemical tools utilizing new molecular biological advances, can simplify the diagnostic and prognostication processes, aiding clinical management.

Read Full Article HTML DOI: 10.29328/journal.cjog.1001165 Cite this Article Read Full Article PDF

Keywords:

Endometrial metaplasia; Morular metaplasia; Atypical endometrial hyperplasia; Endometrioid carcinoma; Conservative treatment; Fertility

References

  1. Giroux V, Rustgi AK. Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence. Nat Rev Cancer. 2017 Oct;17(10):594-604. doi: 10.1038/nrc.2017.68. Epub 2017 Sep 1. PMID: 28860646; PMCID: PMC5998678.
  2. Goyette ERJ, Bentz JL. Endometrial metaplasia. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/uterusmetaplasia.html. Accessed March 15th, 2024.
  3. Travaglino A, Raffone A, Gencarelli A, Raimondo D, Moretta P, Pignatiello S, Granata M, Seracchioli R, Zullo F, Insabato L. Relationship between morular metaplasia and squamous differentiation in endometrial carcinoma. Pathol Res Pract. 2021 Jan;217:153307. doi: 10.1016/j.prp.2020.153307. Epub 2020 Nov 30. PMID: 33316539.
  4. Kujdowicz M, Milewicz T, Adamek D. Extensive squamous metaplasia (morulosis) of the endometrium as a clinical and pathological problem: a case report and literature study. Gynecol Endocrinol. 2020 May;36(5):460-464. doi: 10.1080/09513590.2019.1696304. Epub 2020 Feb 10. PMID: 32037914.
  5. Makishi S, Kinjo T, Sawada S, Chinen K, Hirayasu T, Hamada T, Saito K, Iwamasa T. Morules and morule-like features associated with carcinomas in various organs: report with immunohistochemical and molecular studies. J Clin Pathol. 2006 Jan;59(1):95-100. doi: 10.1136/jcp.2005.026237. PMID: 16394288; PMCID: PMC1860262.
  6. Nicolae A, Preda O, Nogales FF. Endometrial metaplasias and reactive changes: a spectrum of altered differentiation. J Clin Pathol. 2011 Feb;64(2):97-106. doi: 10.1136/jcp.2010.085555. Epub 2010 Dec 1. PMID: 21126963.
  7. Litta P, Codroma A, D'Agostino G, Breda E. Morular endometrial metaplasia: review of the literature and proposal of the management. Eur J Gynaecol Oncol. 2013;34(3):243-7. PMID: 23967555.
  8. Nakatani Y, Masudo K, Miyagi Y, Inayama Y, Kawano N, Tanaka Y, Kato K, Ito T, Kitamura H, Nagashima Y, Yamanaka S, Nakamura N, Sano J, Ogawa N, Ishiwa N, Notohara K, Resl M, Mark EJ. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules. Mod Pathol. 2002 Jun;15(6):617-24. doi: 10.1038/modpathol.3880575. PMID: 12065775.
  9. Travaglino A, Raffone A, Russo D, Guadagno E, Pignatiello S, Moretta P, Zullo F, Del Basso De Caro M, Insabato L, Mascolo M. Does endometrial morular metaplasia represent odontogenic differentiation? Virchows Arch. 2021 Sep;479(3):607-616. doi: 10.1007/s00428-021-03060-2. Epub 2021 Mar 5. PMID: 33666744; PMCID: PMC8448715.
  10. Chiarelli S, Buriticá C, Litta P, Ciani S, Guarch R, Nogales FF. An immunohistochemical study of morules in endometrioid lesions of the female genital tract: CD10 is a characteristic marker of morular metaplasia. Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4251-6. doi: 10.1158/1078-0432.CCR-06-0398. PMID: 16857799.
  11. Zhang Y, Wang X. Targeting the Wnt/β-catenin signaling pathway in cancer. J Hematol Oncol. 2020 Dec 4;13(1):165. doi: 10.1186/s13045-020-00990-3. PMID: 33276800; PMCID: PMC7716495.
  12. Saegusa M, Hashimura M, Yoshida T, Okayasu I. beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis. Br J Cancer. 2001 Jan;84(2):209-17. doi: 10.1054/bjoc.2000.1581. PMID: 11161379; PMCID: PMC2363713.
  13. Saegusa M, Okayasu I. Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. J Pathol. 2001 May;194(1):59-67. doi: 10.1002/path.856. PMID: 11329142.
  14. Kim S, Jeong S. Mutation Hotspots in the β-Catenin Gene: Lessons from the Human Cancer Genome Databases. Mol Cells. 2019 Jan 31;42(1):8-16. doi: 10.14348/molcells.2018.0436. Epub 2019 Jan 7. PMID: 30699286; PMCID: PMC6354055.
  15. Lin MC, Lomo L, Baak JP, Eng C, Ince TA, Crum CP, Mutter GL. Squamous morules are functionally inert elements of premalignant endometrial neoplasia. Mod Pathol. 2009 Feb;22(2):167-74. doi: 10.1038/modpathol.2008.146. Epub 2008 Sep 19. PMID: 19180120; PMCID: PMC2633489.
  16. Kurnit KC, Kim GN, Fellman BM, Urbauer DL, Mills GB, Zhang W, Broaddus RR. CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence. Mod Pathol. 2017 Jul;30(7):1032-1041. doi: 10.1038/modpathol.2017.15. Epub 2017 Mar 10. PMID: 28281553; PMCID: PMC5493522.
  17. Chiarelli S, Buriticá C, Litta P, Ciani S, Guarch R, Nogales FF. An immunohistochemical study of morules in endometrioid lesions of the female genital tract: CD10 is a characteristic marker of morular metaplasia. Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4251-6. doi: 10.1158/1078-0432.CCR-06-0398. PMID: 16857799.
  18. Houghton O, Connolly LE, McCluggage WG. Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2. Histopathology. 2008 Aug;53(2):156-65. doi: 10.1111/j.1365-2559.2008.03083.x. PMID: 18752499.
  19. Patkar R, Mishra S. Extensive morular metaplasia in an endometrial polyp – A rare occurrence - creating a diagnostic dilemma. IP Arch Cytol Histopathology Res. 2023;8(2):126-129.
  20. Zhu S, He L, Zheng C, Hou Y. Bladder mulberry-like fibroepithelial polyp with calcification and squamous cell metaplasia mimicking bladder carcinoma: case report and literature review. J Int Med Res. 2020 Jan;48(1):300060519896911. doi: 10.1177/0300060519896911. PMID: 32008408; PMCID: PMC7113808.

Figures:

Similar Articles

Recently Viewed

  • Characteristics of Juvenile Sex Offenders in Poland
    Anna Więcek-Durańska* Anna Więcek-Durańska*. Characteristics of Juvenile Sex Offenders in Poland. J Forensic Sci Res. 2023: doi: 10.29328/journal.jfsr.1001053; 7: 072-076
  • Hypercalcaemic Crisis Associated with Hyperthyroidism: A Rare and Challenging Presentation
    Karthik Baburaj*, Priya Thottiyil Nair, Abeed Hussain and Vimal MV Karthik Baburaj*, Priya Thottiyil Nair, Abeed Hussain, Vimal MV. Hypercalcaemic Crisis Associated with Hyperthyroidism: A Rare and Challenging Presentation. Ann Clin Endocrinol Metabol. 2024: doi: 10.29328/journal.acem.1001029; 8: 001-003
  • Physicians’ Anxiety Post-COVID Pandemic: A Cross-Sectional Study
    Ismail Hanine*, Mouna Chtibi, Kenza Hajjami, Siham Belbachir, Mohamed Kadiri and Abderrazzak Ouanass Ismail Hanine*, Mouna Chtibi, Kenza Hajjami, Siham Belbachir, Mohamed Kadiri, Abderrazzak Ouanass. Physicians’ Anxiety Post-COVID Pandemic: A Cross-Sectional Study. Arch Psychiatr Ment Health. 2024: doi: 10.29328/journal.apmh.1001054; 8: 032-037
  • Current anesthesıa for Cesarean Sectıon
    Demet Dogan Erol* and Ismail Aytac Demet Dogan Erol*, Ismail Aytac. Current anesthesıa for Cesarean Sectıon. Clin J Obstet Gynecol. 2018: doi: 10.29328/journal.cjog.1001011; 1: 061-066
  • Therapy of Walker Carcinosarcoma with Pectin and Cyclophosphane
    NY Alimzhanov, ISh Chakeev, BN Lepshin, IO Kudaibergenova, BA Shaimurzayeva, LV Serikova and Sh Jorobekova* NY Alimzhanov, ISh Chakeev, BN Lepshin, IO Kudaibergenova, BA Shaimurzayeva, LV Serikova, Sh Jorobekova*. Therapy of Walker Carcinosarcoma with Pectin and Cyclophosphane. J Radiol Oncol. 2023: doi: 10.29328/journal.jro.1001056; 7: 066-070

Read More

Most Viewed

Read More

Help ?